nodes	percent_of_prediction	percent_of_DWPC	metapath
Fesoterodine—CYP2D6—Lomustine—brain cancer	0.227	0.282	CbGbCtD
Fesoterodine—CYP2D6—Hydroxyurea—brain cancer	0.172	0.213	CbGbCtD
Fesoterodine—CYP3A4—Temozolomide—brain cancer	0.17	0.211	CbGbCtD
Fesoterodine—CYP3A4—Lomustine—brain cancer	0.145	0.179	CbGbCtD
Fesoterodine—ABCB1—Etoposide—brain cancer	0.0583	0.0722	CbGbCtD
Fesoterodine—CYP3A4—Etoposide—brain cancer	0.0349	0.0433	CbGbCtD
Fesoterodine—Tolterodine—CYP2C9—brain cancer	0.00482	1	CrCbGaD
Fesoterodine—Hepatic enzyme increased—Hydroxyurea—brain cancer	0.00347	0.0199	CcSEcCtD
Fesoterodine—Gamma-glutamyltransferase increased—Temozolomide—brain cancer	0.00311	0.0178	CcSEcCtD
Fesoterodine—Hepatic enzyme increased—Temozolomide—brain cancer	0.00271	0.0155	CcSEcCtD
Fesoterodine—Infection—Carboplatin—brain cancer	0.0027	0.0155	CcSEcCtD
Fesoterodine—Angina pectoris—Procarbazine—brain cancer	0.00259	0.0148	CcSEcCtD
Fesoterodine—Dry eye—Temozolomide—brain cancer	0.00237	0.0135	CcSEcCtD
Fesoterodine—Infection—Lomustine—brain cancer	0.00237	0.0135	CcSEcCtD
Fesoterodine—Face oedema—Hydroxyurea—brain cancer	0.0023	0.0132	CcSEcCtD
Fesoterodine—Gastroenteritis—Temozolomide—brain cancer	0.0021	0.012	CcSEcCtD
Fesoterodine—Dysuria—Hydroxyurea—brain cancer	0.00192	0.011	CcSEcCtD
Fesoterodine—Face oedema—Carmustine—brain cancer	0.00186	0.0106	CcSEcCtD
Fesoterodine—Infestation NOS—Hydroxyurea—brain cancer	0.00183	0.0105	CcSEcCtD
Fesoterodine—Infestation—Hydroxyurea—brain cancer	0.00183	0.0105	CcSEcCtD
Fesoterodine—Face oedema—Temozolomide—brain cancer	0.0018	0.0103	CcSEcCtD
Fesoterodine—Hepatobiliary disease—Hydroxyurea—brain cancer	0.00173	0.00993	CcSEcCtD
Fesoterodine—Dry skin—Temozolomide—brain cancer	0.0017	0.00976	CcSEcCtD
Fesoterodine—Alanine aminotransferase increased—Temozolomide—brain cancer	0.00164	0.00939	CcSEcCtD
Fesoterodine—Cough—Procarbazine—brain cancer	0.00162	0.00925	CcSEcCtD
Fesoterodine—Dry mouth—Procarbazine—brain cancer	0.00154	0.00883	CcSEcCtD
Fesoterodine—Confusional state—Procarbazine—brain cancer	0.00152	0.00873	CcSEcCtD
Fesoterodine—Dysuria—Temozolomide—brain cancer	0.0015	0.00861	CcSEcCtD
Fesoterodine—Infection—Procarbazine—brain cancer	0.0015	0.0086	CcSEcCtD
Fesoterodine—Upper respiratory tract infection—Temozolomide—brain cancer	0.00149	0.00855	CcSEcCtD
Fesoterodine—Tachycardia—Procarbazine—brain cancer	0.00148	0.00845	CcSEcCtD
Fesoterodine—Urinary tract infection—Carmustine—brain cancer	0.00144	0.00825	CcSEcCtD
Fesoterodine—Infestation NOS—Temozolomide—brain cancer	0.00143	0.00821	CcSEcCtD
Fesoterodine—Infestation—Temozolomide—brain cancer	0.00143	0.00821	CcSEcCtD
Fesoterodine—Nausea—Lomustine—brain cancer	0.00141	0.0081	CcSEcCtD
Fesoterodine—Urinary tract infection—Temozolomide—brain cancer	0.00139	0.00798	CcSEcCtD
Fesoterodine—Insomnia—Procarbazine—brain cancer	0.00137	0.00783	CcSEcCtD
Fesoterodine—Hepatobiliary disease—Temozolomide—brain cancer	0.00136	0.00776	CcSEcCtD
Fesoterodine—Somnolence—Procarbazine—brain cancer	0.00134	0.00769	CcSEcCtD
Fesoterodine—Alanine aminotransferase increased—Etoposide—brain cancer	0.00131	0.00751	CcSEcCtD
Fesoterodine—Oedema peripheral—Carmustine—brain cancer	0.00131	0.00751	CcSEcCtD
Fesoterodine—Fatigue—Procarbazine—brain cancer	0.0013	0.00746	CcSEcCtD
Fesoterodine—Constipation—Procarbazine—brain cancer	0.00129	0.0074	CcSEcCtD
Fesoterodine—Urinary tract disorder—Temozolomide—brain cancer	0.00127	0.00727	CcSEcCtD
Fesoterodine—Oedema peripheral—Temozolomide—brain cancer	0.00127	0.00726	CcSEcCtD
Fesoterodine—Urethral disorder—Temozolomide—brain cancer	0.00126	0.00722	CcSEcCtD
Fesoterodine—Feeling abnormal—Procarbazine—brain cancer	0.00125	0.00713	CcSEcCtD
Fesoterodine—Eye disorder—Carmustine—brain cancer	0.00124	0.00712	CcSEcCtD
Fesoterodine—Gastrointestinal pain—Procarbazine—brain cancer	0.00124	0.00708	CcSEcCtD
Fesoterodine—Unspecified disorder of skin and subcutaneous tissue—Hydroxyurea—brain cancer	0.00121	0.00694	CcSEcCtD
Fesoterodine—Eye disorder—Temozolomide—brain cancer	0.0012	0.00688	CcSEcCtD
Fesoterodine—Urticaria—Procarbazine—brain cancer	0.0012	0.00688	CcSEcCtD
Fesoterodine—Abdominal pain—Procarbazine—brain cancer	0.0012	0.00684	CcSEcCtD
Fesoterodine—Cardiac disorder—Temozolomide—brain cancer	0.00119	0.00684	CcSEcCtD
Fesoterodine—Mental disorder—Carmustine—brain cancer	0.00117	0.00668	CcSEcCtD
Fesoterodine—Infection—Hydroxyurea—brain cancer	0.00116	0.00665	CcSEcCtD
Fesoterodine—Mediastinal disorder—Temozolomide—brain cancer	0.00116	0.00664	CcSEcCtD
Fesoterodine—Nervous system disorder—Hydroxyurea—brain cancer	0.00115	0.00657	CcSEcCtD
Fesoterodine—Infestation NOS—Etoposide—brain cancer	0.00115	0.00657	CcSEcCtD
Fesoterodine—Infestation—Etoposide—brain cancer	0.00115	0.00657	CcSEcCtD
Fesoterodine—Skin disorder—Hydroxyurea—brain cancer	0.00114	0.00651	CcSEcCtD
Fesoterodine—Mental disorder—Temozolomide—brain cancer	0.00113	0.00645	CcSEcCtD
Fesoterodine—Back pain—Carmustine—brain cancer	0.00112	0.00642	CcSEcCtD
Fesoterodine—Hypersensitivity—Procarbazine—brain cancer	0.00111	0.00638	CcSEcCtD
Fesoterodine—Dysgeusia—Temozolomide—brain cancer	0.0011	0.00628	CcSEcCtD
Fesoterodine—Vision blurred—Carmustine—brain cancer	0.00109	0.00625	CcSEcCtD
Fesoterodine—Asthenia—Procarbazine—brain cancer	0.00108	0.00621	CcSEcCtD
Fesoterodine—Hepatobiliary disease—Etoposide—brain cancer	0.00108	0.00621	CcSEcCtD
Fesoterodine—Back pain—Temozolomide—brain cancer	0.00108	0.0062	CcSEcCtD
Fesoterodine—Pruritus—Procarbazine—brain cancer	0.00107	0.00612	CcSEcCtD
Fesoterodine—Vision blurred—Temozolomide—brain cancer	0.00106	0.00604	CcSEcCtD
Fesoterodine—Somnolence—Hydroxyurea—brain cancer	0.00104	0.00596	CcSEcCtD
Fesoterodine—Diarrhoea—Procarbazine—brain cancer	0.00103	0.00592	CcSEcCtD
Fesoterodine—Dyspepsia—Hydroxyurea—brain cancer	0.00103	0.0059	CcSEcCtD
Fesoterodine—Angioedema—Temozolomide—brain cancer	0.00102	0.00586	CcSEcCtD
Fesoterodine—Urinary tract disorder—Etoposide—brain cancer	0.00102	0.00582	CcSEcCtD
Fesoterodine—Gastrointestinal disorder—Hydroxyurea—brain cancer	0.00101	0.00578	CcSEcCtD
Fesoterodine—Urethral disorder—Etoposide—brain cancer	0.00101	0.00578	CcSEcCtD
Fesoterodine—Fatigue—Hydroxyurea—brain cancer	0.00101	0.00578	CcSEcCtD
Fesoterodine—Vertigo—Temozolomide—brain cancer	0.00101	0.00576	CcSEcCtD
Fesoterodine—Constipation—Hydroxyurea—brain cancer	0.001	0.00573	CcSEcCtD
Fesoterodine—Dizziness—Procarbazine—brain cancer	0.001	0.00572	CcSEcCtD
Fesoterodine—Palpitations—Temozolomide—brain cancer	0.00099	0.00567	CcSEcCtD
Fesoterodine—Chest pain—Carmustine—brain cancer	0.000987	0.00565	CcSEcCtD
Fesoterodine—Cough—Temozolomide—brain cancer	0.000977	0.0056	CcSEcCtD
Fesoterodine—Feeling abnormal—Hydroxyurea—brain cancer	0.000964	0.00552	CcSEcCtD
Fesoterodine—Eye disorder—Etoposide—brain cancer	0.000962	0.00551	CcSEcCtD
Fesoterodine—Cardiac disorder—Etoposide—brain cancer	0.000955	0.00547	CcSEcCtD
Fesoterodine—Confusional state—Carmustine—brain cancer	0.000954	0.00546	CcSEcCtD
Fesoterodine—Rash—Procarbazine—brain cancer	0.000953	0.00546	CcSEcCtD
Fesoterodine—Dermatitis—Procarbazine—brain cancer	0.000952	0.00545	CcSEcCtD
Fesoterodine—Headache—Procarbazine—brain cancer	0.000947	0.00542	CcSEcCtD
Fesoterodine—Unspecified disorder of skin and subcutaneous tissue—Temozolomide—brain cancer	0.000947	0.00542	CcSEcCtD
Fesoterodine—Infection—Carmustine—brain cancer	0.00094	0.00538	CcSEcCtD
Fesoterodine—Dry mouth—Temozolomide—brain cancer	0.000932	0.00534	CcSEcCtD
Fesoterodine—Mediastinal disorder—Etoposide—brain cancer	0.000928	0.00531	CcSEcCtD
Fesoterodine—Tachycardia—Carmustine—brain cancer	0.000923	0.00529	CcSEcCtD
Fesoterodine—Confusional state—Temozolomide—brain cancer	0.000922	0.00528	CcSEcCtD
Fesoterodine—Infection—Temozolomide—brain cancer	0.000908	0.0052	CcSEcCtD
Fesoterodine—Nausea—Procarbazine—brain cancer	0.000898	0.00514	CcSEcCtD
Fesoterodine—Nervous system disorder—Temozolomide—brain cancer	0.000896	0.00513	CcSEcCtD
Fesoterodine—Skin disorder—Temozolomide—brain cancer	0.000888	0.00508	CcSEcCtD
Fesoterodine—Dysgeusia—Etoposide—brain cancer	0.000878	0.00502	CcSEcCtD
Fesoterodine—Back pain—Etoposide—brain cancer	0.000867	0.00496	CcSEcCtD
Fesoterodine—Hypersensitivity—Hydroxyurea—brain cancer	0.000862	0.00494	CcSEcCtD
Fesoterodine—Insomnia—Carmustine—brain cancer	0.000855	0.0049	CcSEcCtD
Fesoterodine—Somnolence—Carmustine—brain cancer	0.000841	0.00481	CcSEcCtD
Fesoterodine—Asthenia—Hydroxyurea—brain cancer	0.000839	0.00481	CcSEcCtD
Fesoterodine—Insomnia—Temozolomide—brain cancer	0.000827	0.00473	CcSEcCtD
Fesoterodine—Gastrointestinal disorder—Carmustine—brain cancer	0.000817	0.00468	CcSEcCtD
Fesoterodine—Somnolence—Temozolomide—brain cancer	0.000813	0.00465	CcSEcCtD
Fesoterodine—Constipation—Carmustine—brain cancer	0.000809	0.00463	CcSEcCtD
Fesoterodine—Vertigo—Etoposide—brain cancer	0.000805	0.00461	CcSEcCtD
Fesoterodine—Dyspepsia—Temozolomide—brain cancer	0.000805	0.00461	CcSEcCtD
Fesoterodine—Diarrhoea—Hydroxyurea—brain cancer	0.000801	0.00458	CcSEcCtD
Fesoterodine—Gastrointestinal disorder—Temozolomide—brain cancer	0.000789	0.00452	CcSEcCtD
Fesoterodine—Fatigue—Temozolomide—brain cancer	0.000788	0.00451	CcSEcCtD
Fesoterodine—Cough—Etoposide—brain cancer	0.000782	0.00448	CcSEcCtD
Fesoterodine—Constipation—Temozolomide—brain cancer	0.000782	0.00448	CcSEcCtD
Fesoterodine—Feeling abnormal—Carmustine—brain cancer	0.000779	0.00446	CcSEcCtD
Fesoterodine—Dizziness—Hydroxyurea—brain cancer	0.000774	0.00443	CcSEcCtD
Fesoterodine—Gastrointestinal pain—Carmustine—brain cancer	0.000773	0.00443	CcSEcCtD
Fesoterodine—Chest pain—Etoposide—brain cancer	0.000763	0.00437	CcSEcCtD
Fesoterodine—Unspecified disorder of skin and subcutaneous tissue—Etoposide—brain cancer	0.000758	0.00434	CcSEcCtD
Fesoterodine—Feeling abnormal—Temozolomide—brain cancer	0.000753	0.00431	CcSEcCtD
Fesoterodine—Abdominal pain—Carmustine—brain cancer	0.000748	0.00428	CcSEcCtD
Fesoterodine—Gastrointestinal pain—Temozolomide—brain cancer	0.000747	0.00428	CcSEcCtD
Fesoterodine—Rash—Hydroxyurea—brain cancer	0.000738	0.00422	CcSEcCtD
Fesoterodine—Confusional state—Etoposide—brain cancer	0.000737	0.00422	CcSEcCtD
Fesoterodine—Dermatitis—Hydroxyurea—brain cancer	0.000737	0.00422	CcSEcCtD
Fesoterodine—Headache—Hydroxyurea—brain cancer	0.000733	0.0042	CcSEcCtD
Fesoterodine—Infection—Etoposide—brain cancer	0.000727	0.00416	CcSEcCtD
Fesoterodine—Urticaria—Temozolomide—brain cancer	0.000726	0.00416	CcSEcCtD
Fesoterodine—Abdominal pain—Temozolomide—brain cancer	0.000723	0.00414	CcSEcCtD
Fesoterodine—Tachycardia—Etoposide—brain cancer	0.000714	0.00409	CcSEcCtD
Fesoterodine—Skin disorder—Etoposide—brain cancer	0.00071	0.00407	CcSEcCtD
Fesoterodine—Hypersensitivity—Carmustine—brain cancer	0.000697	0.00399	CcSEcCtD
Fesoterodine—Nausea—Hydroxyurea—brain cancer	0.000695	0.00398	CcSEcCtD
Fesoterodine—Asthenia—Carmustine—brain cancer	0.000679	0.00389	CcSEcCtD
Fesoterodine—Hypersensitivity—Temozolomide—brain cancer	0.000673	0.00386	CcSEcCtD
Fesoterodine—Asthenia—Temozolomide—brain cancer	0.000656	0.00375	CcSEcCtD
Fesoterodine—Somnolence—Etoposide—brain cancer	0.00065	0.00372	CcSEcCtD
Fesoterodine—Diarrhoea—Carmustine—brain cancer	0.000647	0.00371	CcSEcCtD
Fesoterodine—Pruritus—Temozolomide—brain cancer	0.000647	0.0037	CcSEcCtD
Fesoterodine—Gastrointestinal disorder—Etoposide—brain cancer	0.000631	0.00362	CcSEcCtD
Fesoterodine—Fatigue—Etoposide—brain cancer	0.000631	0.00361	CcSEcCtD
Fesoterodine—Dizziness—Carmustine—brain cancer	0.000625	0.00358	CcSEcCtD
Fesoterodine—Constipation—Etoposide—brain cancer	0.000625	0.00358	CcSEcCtD
Fesoterodine—Diarrhoea—Temozolomide—brain cancer	0.000625	0.00358	CcSEcCtD
Fesoterodine—Dizziness—Temozolomide—brain cancer	0.000604	0.00346	CcSEcCtD
Fesoterodine—Feeling abnormal—Etoposide—brain cancer	0.000603	0.00345	CcSEcCtD
Fesoterodine—Gastrointestinal pain—Etoposide—brain cancer	0.000598	0.00342	CcSEcCtD
Fesoterodine—Rash—Carmustine—brain cancer	0.000596	0.00341	CcSEcCtD
Fesoterodine—Dermatitis—Carmustine—brain cancer	0.000596	0.00341	CcSEcCtD
Fesoterodine—Headache—Carmustine—brain cancer	0.000593	0.00339	CcSEcCtD
Fesoterodine—Urticaria—Etoposide—brain cancer	0.000581	0.00333	CcSEcCtD
Fesoterodine—Abdominal pain—Etoposide—brain cancer	0.000578	0.00331	CcSEcCtD
Fesoterodine—Rash—Temozolomide—brain cancer	0.000576	0.0033	CcSEcCtD
Fesoterodine—Dermatitis—Temozolomide—brain cancer	0.000576	0.0033	CcSEcCtD
Fesoterodine—Headache—Temozolomide—brain cancer	0.000573	0.00328	CcSEcCtD
Fesoterodine—Nausea—Carmustine—brain cancer	0.000562	0.00322	CcSEcCtD
Fesoterodine—Nausea—Temozolomide—brain cancer	0.000543	0.00311	CcSEcCtD
Fesoterodine—Hypersensitivity—Etoposide—brain cancer	0.000539	0.00309	CcSEcCtD
Fesoterodine—Asthenia—Etoposide—brain cancer	0.000525	0.003	CcSEcCtD
Fesoterodine—Pruritus—Etoposide—brain cancer	0.000517	0.00296	CcSEcCtD
Fesoterodine—Diarrhoea—Etoposide—brain cancer	0.0005	0.00287	CcSEcCtD
Fesoterodine—Dizziness—Etoposide—brain cancer	0.000484	0.00277	CcSEcCtD
Fesoterodine—Rash—Etoposide—brain cancer	0.000461	0.00264	CcSEcCtD
Fesoterodine—Dermatitis—Etoposide—brain cancer	0.000461	0.00264	CcSEcCtD
Fesoterodine—Headache—Etoposide—brain cancer	0.000458	0.00262	CcSEcCtD
Fesoterodine—Nausea—Etoposide—brain cancer	0.000434	0.00249	CcSEcCtD
Fesoterodine—CHRM4—Signaling by GPCR—PTCH1—brain cancer	2.25e-05	0.0017	CbGpPWpGaD
Fesoterodine—CHRM4—Signaling by GPCR—SMO—brain cancer	2.25e-05	0.0017	CbGpPWpGaD
Fesoterodine—CHRM2—SIDS Susceptibility Pathways—CTNNB1—brain cancer	2.2e-05	0.00166	CbGpPWpGaD
Fesoterodine—CHRM5—Signaling by GPCR—TRPC6—brain cancer	2.19e-05	0.00166	CbGpPWpGaD
Fesoterodine—ABCB1—Integrated Pancreatic Cancer Pathway—PCNA—brain cancer	2.17e-05	0.00164	CbGpPWpGaD
Fesoterodine—CHRM5—Signaling by GPCR—SMO—brain cancer	2.15e-05	0.00163	CbGpPWpGaD
Fesoterodine—CHRM5—Signaling by GPCR—PTCH1—brain cancer	2.15e-05	0.00163	CbGpPWpGaD
Fesoterodine—ABCB1—Allograft Rejection—VEGFA—brain cancer	2.14e-05	0.00162	CbGpPWpGaD
Fesoterodine—CHRM4—Signaling Pathways—ABR—brain cancer	2.14e-05	0.00161	CbGpPWpGaD
Fesoterodine—CHRM4—Signaling Pathways—GLI2—brain cancer	2.06e-05	0.00156	CbGpPWpGaD
Fesoterodine—CHRM5—Signaling Pathways—ABR—brain cancer	2.04e-05	0.00155	CbGpPWpGaD
Fesoterodine—CHRM5—Signaling Pathways—GLI2—brain cancer	1.97e-05	0.00149	CbGpPWpGaD
Fesoterodine—CHRM3—Metabolism—CYP2C9—brain cancer	1.95e-05	0.00147	CbGpPWpGaD
Fesoterodine—CHRM4—Signaling Pathways—GLI1—brain cancer	1.94e-05	0.00147	CbGpPWpGaD
Fesoterodine—CHRM5—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—brain cancer	1.94e-05	0.00147	CbGpPWpGaD
Fesoterodine—CHRM2—SIDS Susceptibility Pathways—VEGFA—brain cancer	1.94e-05	0.00146	CbGpPWpGaD
Fesoterodine—CHRM4—GPCR downstream signaling—VAV1—brain cancer	1.89e-05	0.00143	CbGpPWpGaD
Fesoterodine—ABCB1—Integrated Pancreatic Cancer Pathway—CDK4—brain cancer	1.87e-05	0.00142	CbGpPWpGaD
Fesoterodine—CHRM5—Signaling Pathways—GLI1—brain cancer	1.86e-05	0.0014	CbGpPWpGaD
Fesoterodine—CHRM4—Signaling Pathways—SUFU—brain cancer	1.84e-05	0.00139	CbGpPWpGaD
Fesoterodine—CHRM1—Signaling Pathways—PTCH2—brain cancer	1.83e-05	0.00139	CbGpPWpGaD
Fesoterodine—CHRM1—Regulation of Actin Cytoskeleton—EGFR—brain cancer	1.83e-05	0.00138	CbGpPWpGaD
Fesoterodine—CHRM3—Signaling Pathways—PTCH2—brain cancer	1.83e-05	0.00138	CbGpPWpGaD
Fesoterodine—CHRM3—Regulation of Actin Cytoskeleton—EGFR—brain cancer	1.82e-05	0.00138	CbGpPWpGaD
Fesoterodine—CHRM2—Signaling Pathways—PTCH2—brain cancer	1.81e-05	0.00137	CbGpPWpGaD
Fesoterodine—CHRM5—GPCR downstream signaling—VAV1—brain cancer	1.81e-05	0.00137	CbGpPWpGaD
Fesoterodine—CHRM2—Regulation of Actin Cytoskeleton—EGFR—brain cancer	1.81e-05	0.00137	CbGpPWpGaD
Fesoterodine—CHRM1—Signaling Pathways—HES5—brain cancer	1.78e-05	0.00134	CbGpPWpGaD
Fesoterodine—CHRM4—Signaling Pathways—GFAP—brain cancer	1.77e-05	0.00134	CbGpPWpGaD
Fesoterodine—CHRM3—Signaling Pathways—HES5—brain cancer	1.77e-05	0.00134	CbGpPWpGaD
Fesoterodine—ABCB1—Integrated Pancreatic Cancer Pathway—APC—brain cancer	1.76e-05	0.00133	CbGpPWpGaD
Fesoterodine—CHRM5—Signaling Pathways—SUFU—brain cancer	1.76e-05	0.00133	CbGpPWpGaD
Fesoterodine—CHRM2—Signaling Pathways—HES5—brain cancer	1.75e-05	0.00133	CbGpPWpGaD
Fesoterodine—CHRM1—Signaling Pathways—STRADA—brain cancer	1.73e-05	0.0013	CbGpPWpGaD
Fesoterodine—CHRM3—Signaling Pathways—STRADA—brain cancer	1.72e-05	0.0013	CbGpPWpGaD
Fesoterodine—CHRM4—Signaling by GPCR—VAV1—brain cancer	1.71e-05	0.0013	CbGpPWpGaD
Fesoterodine—CHRM2—Signaling Pathways—STRADA—brain cancer	1.7e-05	0.00129	CbGpPWpGaD
Fesoterodine—CHRM1—GPCR downstream signaling—TRPC6—brain cancer	1.7e-05	0.00128	CbGpPWpGaD
Fesoterodine—CHRM5—Signaling Pathways—GFAP—brain cancer	1.7e-05	0.00128	CbGpPWpGaD
Fesoterodine—CHRM3—GPCR downstream signaling—TRPC6—brain cancer	1.69e-05	0.00128	CbGpPWpGaD
Fesoterodine—CHRM4—Signaling Pathways—HEY1—brain cancer	1.68e-05	0.00127	CbGpPWpGaD
Fesoterodine—CHRM2—GPCR downstream signaling—TRPC6—brain cancer	1.68e-05	0.00127	CbGpPWpGaD
Fesoterodine—CHRM3—Metabolism—BSG—brain cancer	1.66e-05	0.00125	CbGpPWpGaD
Fesoterodine—CHRM4—Signaling Pathways—DLL1—brain cancer	1.65e-05	0.00125	CbGpPWpGaD
Fesoterodine—CHRM5—Signaling by GPCR—VAV1—brain cancer	1.64e-05	0.00124	CbGpPWpGaD
Fesoterodine—CHRM5—Signaling Pathways—HEY1—brain cancer	1.61e-05	0.00122	CbGpPWpGaD
Fesoterodine—CHRM1—Signaling by GPCR—SHH—brain cancer	1.6e-05	0.00121	CbGpPWpGaD
Fesoterodine—CHRM3—Signaling by GPCR—SHH—brain cancer	1.59e-05	0.00121	CbGpPWpGaD
Fesoterodine—CHRM2—Signaling by GPCR—SHH—brain cancer	1.58e-05	0.00119	CbGpPWpGaD
Fesoterodine—CHRM5—Signaling Pathways—DLL1—brain cancer	1.58e-05	0.00119	CbGpPWpGaD
Fesoterodine—CHRM1—Signaling by GPCR—TRPC6—brain cancer	1.54e-05	0.00117	CbGpPWpGaD
Fesoterodine—CHRM3—Signaling by GPCR—TRPC6—brain cancer	1.54e-05	0.00116	CbGpPWpGaD
Fesoterodine—CHRM2—Signaling by GPCR—TRPC6—brain cancer	1.52e-05	0.00115	CbGpPWpGaD
Fesoterodine—CHRM1—Signaling by GPCR—SMO—brain cancer	1.52e-05	0.00115	CbGpPWpGaD
Fesoterodine—CHRM1—Signaling by GPCR—PTCH1—brain cancer	1.52e-05	0.00115	CbGpPWpGaD
Fesoterodine—CHRM3—Signaling by GPCR—PTCH1—brain cancer	1.51e-05	0.00114	CbGpPWpGaD
Fesoterodine—CHRM3—Signaling by GPCR—SMO—brain cancer	1.51e-05	0.00114	CbGpPWpGaD
Fesoterodine—CHRM2—Signaling by GPCR—SMO—brain cancer	1.5e-05	0.00113	CbGpPWpGaD
Fesoterodine—CHRM2—Signaling by GPCR—PTCH1—brain cancer	1.5e-05	0.00113	CbGpPWpGaD
Fesoterodine—ABCB1—Transmembrane transport of small molecules—TRPC6—brain cancer	1.47e-05	0.00111	CbGpPWpGaD
Fesoterodine—CHRM1—Signaling Pathways—ABR—brain cancer	1.44e-05	0.00109	CbGpPWpGaD
Fesoterodine—CHRM3—Signaling Pathways—ABR—brain cancer	1.44e-05	0.00109	CbGpPWpGaD
Fesoterodine—CHRM3—Metabolism—IDH1—brain cancer	1.43e-05	0.00108	CbGpPWpGaD
Fesoterodine—CHRM2—Signaling Pathways—ABR—brain cancer	1.42e-05	0.00107	CbGpPWpGaD
Fesoterodine—CHRM4—Signaling Pathways—SHH—brain cancer	1.4e-05	0.00106	CbGpPWpGaD
Fesoterodine—CHRM1—Signaling Pathways—GLI2—brain cancer	1.39e-05	0.00105	CbGpPWpGaD
Fesoterodine—CHRM3—Signaling Pathways—GLI2—brain cancer	1.39e-05	0.00105	CbGpPWpGaD
Fesoterodine—CHRM2—Signaling Pathways—GLI2—brain cancer	1.37e-05	0.00104	CbGpPWpGaD
Fesoterodine—ABCB1—Integrated Pancreatic Cancer Pathway—ERBB2—brain cancer	1.37e-05	0.00104	CbGpPWpGaD
Fesoterodine—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—brain cancer	1.37e-05	0.00103	CbGpPWpGaD
Fesoterodine—CHRM3—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—brain cancer	1.36e-05	0.00103	CbGpPWpGaD
Fesoterodine—CHRM4—Signaling Pathways—TRPC6—brain cancer	1.35e-05	0.00102	CbGpPWpGaD
Fesoterodine—CHRM5—Signaling Pathways—SHH—brain cancer	1.34e-05	0.00102	CbGpPWpGaD
Fesoterodine—CHRM4—Signaling Pathways—PTCH1—brain cancer	1.33e-05	0.001	CbGpPWpGaD
Fesoterodine—CHRM4—Signaling Pathways—SMO—brain cancer	1.33e-05	0.001	CbGpPWpGaD
Fesoterodine—CHRM1—Signaling Pathways—GLI1—brain cancer	1.31e-05	0.000989	CbGpPWpGaD
Fesoterodine—CHRM3—Signaling Pathways—GLI1—brain cancer	1.3e-05	0.000985	CbGpPWpGaD
Fesoterodine—CHRM5—Signaling Pathways—TRPC6—brain cancer	1.29e-05	0.000979	CbGpPWpGaD
Fesoterodine—CHRM2—Signaling Pathways—GLI1—brain cancer	1.29e-05	0.000976	CbGpPWpGaD
Fesoterodine—CHRM1—GPCR downstream signaling—VAV1—brain cancer	1.27e-05	0.000963	CbGpPWpGaD
Fesoterodine—CHRM5—Signaling Pathways—SMO—brain cancer	1.27e-05	0.000962	CbGpPWpGaD
Fesoterodine—CHRM5—Signaling Pathways—PTCH1—brain cancer	1.27e-05	0.000962	CbGpPWpGaD
Fesoterodine—CHRM3—GPCR downstream signaling—VAV1—brain cancer	1.27e-05	0.000959	CbGpPWpGaD
Fesoterodine—CHRM2—GPCR downstream signaling—VAV1—brain cancer	1.26e-05	0.00095	CbGpPWpGaD
Fesoterodine—CHRM1—Signaling Pathways—SUFU—brain cancer	1.24e-05	0.000937	CbGpPWpGaD
Fesoterodine—ABCB1—Metabolism—CYP2C9—brain cancer	1.24e-05	0.000935	CbGpPWpGaD
Fesoterodine—CHRM3—Signaling Pathways—SUFU—brain cancer	1.24e-05	0.000934	CbGpPWpGaD
Fesoterodine—CHRM2—Signaling Pathways—SUFU—brain cancer	1.22e-05	0.000925	CbGpPWpGaD
Fesoterodine—ABCB1—Integrated Pancreatic Cancer Pathway—CCND1—brain cancer	1.21e-05	0.000915	CbGpPWpGaD
Fesoterodine—CHRM1—Circadian rythm related genes—TP53—brain cancer	1.21e-05	0.000915	CbGpPWpGaD
Fesoterodine—CHRM4—GPCR downstream signaling—PIK3CG—brain cancer	1.2e-05	0.000906	CbGpPWpGaD
Fesoterodine—ABCB1—Integrated Pancreatic Cancer Pathway—CTNNB1—brain cancer	1.2e-05	0.000906	CbGpPWpGaD
Fesoterodine—CHRM1—Signaling Pathways—GFAP—brain cancer	1.2e-05	0.000904	CbGpPWpGaD
Fesoterodine—CHRM3—Signaling Pathways—GFAP—brain cancer	1.19e-05	0.000901	CbGpPWpGaD
Fesoterodine—CHRM2—Signaling Pathways—GFAP—brain cancer	1.18e-05	0.000892	CbGpPWpGaD
Fesoterodine—CYP2D6—Metabolism—CYP2C9—brain cancer	1.17e-05	0.000881	CbGpPWpGaD
Fesoterodine—CHRM1—Signaling by GPCR—VAV1—brain cancer	1.16e-05	0.000874	CbGpPWpGaD
Fesoterodine—CHRM3—Signaling by GPCR—VAV1—brain cancer	1.15e-05	0.000871	CbGpPWpGaD
Fesoterodine—CHRM5—GPCR downstream signaling—PIK3CG—brain cancer	1.15e-05	0.000868	CbGpPWpGaD
Fesoterodine—CHRM2—Signaling by GPCR—VAV1—brain cancer	1.14e-05	0.000863	CbGpPWpGaD
Fesoterodine—CHRM1—Signaling Pathways—HEY1—brain cancer	1.13e-05	0.000857	CbGpPWpGaD
Fesoterodine—CHRM3—Signaling Pathways—HEY1—brain cancer	1.13e-05	0.000854	CbGpPWpGaD
Fesoterodine—CHRM3—Metabolism—ENO2—brain cancer	1.13e-05	0.000852	CbGpPWpGaD
Fesoterodine—CHRM2—Signaling Pathways—HEY1—brain cancer	1.12e-05	0.000846	CbGpPWpGaD
Fesoterodine—CHRM1—Signaling Pathways—DLL1—brain cancer	1.11e-05	0.000841	CbGpPWpGaD
Fesoterodine—CHRM3—Signaling Pathways—DLL1—brain cancer	1.11e-05	0.000838	CbGpPWpGaD
Fesoterodine—CHRM2—Signaling Pathways—DLL1—brain cancer	1.1e-05	0.00083	CbGpPWpGaD
Fesoterodine—CHRM4—Signaling by GPCR—PIK3CG—brain cancer	1.09e-05	0.000823	CbGpPWpGaD
Fesoterodine—CHRM4—Signaling Pathways—NOTCH2—brain cancer	1.06e-05	0.000803	CbGpPWpGaD
Fesoterodine—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—brain cancer	1.05e-05	0.000798	CbGpPWpGaD
Fesoterodine—ABCB1—Metabolism—BSG—brain cancer	1.05e-05	0.000795	CbGpPWpGaD
Fesoterodine—CHRM5—Signaling by GPCR—PIK3CG—brain cancer	1.04e-05	0.000788	CbGpPWpGaD
Fesoterodine—CHRM5—Signaling Pathways—NOTCH2—brain cancer	1.02e-05	0.000769	CbGpPWpGaD
Fesoterodine—CHRM4—Signaling Pathways—VAV1—brain cancer	1.01e-05	0.000766	CbGpPWpGaD
Fesoterodine—CYP2D6—Metabolism—BSG—brain cancer	9.91e-06	0.000749	CbGpPWpGaD
Fesoterodine—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—brain cancer	9.7e-06	0.000734	CbGpPWpGaD
Fesoterodine—CHRM5—Signaling Pathways—VAV1—brain cancer	9.7e-06	0.000733	CbGpPWpGaD
Fesoterodine—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—brain cancer	9.49e-06	0.000718	CbGpPWpGaD
Fesoterodine—CHRM1—Signaling Pathways—SHH—brain cancer	9.45e-06	0.000715	CbGpPWpGaD
Fesoterodine—CHRM3—Signaling Pathways—SHH—brain cancer	9.42e-06	0.000712	CbGpPWpGaD
Fesoterodine—CHRM2—Signaling Pathways—SHH—brain cancer	9.33e-06	0.000705	CbGpPWpGaD
Fesoterodine—CHRM1—Signaling Pathways—TRPC6—brain cancer	9.11e-06	0.000689	CbGpPWpGaD
Fesoterodine—CHRM3—Signaling Pathways—TRPC6—brain cancer	9.09e-06	0.000687	CbGpPWpGaD
Fesoterodine—ABCB1—Metabolism—IDH1—brain cancer	9.04e-06	0.000684	CbGpPWpGaD
Fesoterodine—CHRM2—Signaling Pathways—TRPC6—brain cancer	9e-06	0.00068	CbGpPWpGaD
Fesoterodine—CHRM1—Signaling Pathways—PTCH1—brain cancer	8.96e-06	0.000678	CbGpPWpGaD
Fesoterodine—CHRM1—Signaling Pathways—SMO—brain cancer	8.96e-06	0.000678	CbGpPWpGaD
Fesoterodine—CHRM3—Signaling Pathways—PTCH1—brain cancer	8.93e-06	0.000675	CbGpPWpGaD
Fesoterodine—CHRM3—Signaling Pathways—SMO—brain cancer	8.93e-06	0.000675	CbGpPWpGaD
Fesoterodine—CHRM2—Signaling Pathways—SMO—brain cancer	8.85e-06	0.000669	CbGpPWpGaD
Fesoterodine—CHRM2—Signaling Pathways—PTCH1—brain cancer	8.85e-06	0.000669	CbGpPWpGaD
Fesoterodine—CHRM4—Signaling Pathways—HES1—brain cancer	8.71e-06	0.000659	CbGpPWpGaD
Fesoterodine—CYP2D6—Metabolism—IDH1—brain cancer	8.52e-06	0.000644	CbGpPWpGaD
Fesoterodine—CHRM4—GPCR downstream signaling—IL2—brain cancer	8.44e-06	0.000638	CbGpPWpGaD
Fesoterodine—CHRM5—Signaling Pathways—HES1—brain cancer	8.34e-06	0.000631	CbGpPWpGaD
Fesoterodine—CHRM4—Signaling Pathways—PDGFRA—brain cancer	8.29e-06	0.000627	CbGpPWpGaD
Fesoterodine—CHRM1—GPCR downstream signaling—PIK3CG—brain cancer	8.08e-06	0.000611	CbGpPWpGaD
Fesoterodine—CHRM5—GPCR downstream signaling—IL2—brain cancer	8.08e-06	0.000611	CbGpPWpGaD
Fesoterodine—CHRM3—GPCR downstream signaling—PIK3CG—brain cancer	8.06e-06	0.000609	CbGpPWpGaD
Fesoterodine—CHRM4—Signaling Pathways—SPP1—brain cancer	8.05e-06	0.000609	CbGpPWpGaD
Fesoterodine—CHRM2—GPCR downstream signaling—PIK3CG—brain cancer	7.98e-06	0.000603	CbGpPWpGaD
Fesoterodine—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—brain cancer	7.97e-06	0.000603	CbGpPWpGaD
Fesoterodine—CHRM5—Signaling Pathways—PDGFRA—brain cancer	7.94e-06	0.000601	CbGpPWpGaD
Fesoterodine—CHRM5—Signaling Pathways—SPP1—brain cancer	7.71e-06	0.000583	CbGpPWpGaD
Fesoterodine—CHRM4—Signaling by GPCR—IL2—brain cancer	7.66e-06	0.000579	CbGpPWpGaD
Fesoterodine—CYP3A4—Metabolism—CYP2C9—brain cancer	7.62e-06	0.000576	CbGpPWpGaD
Fesoterodine—CHRM1—Signaling by GPCR—PIK3CG—brain cancer	7.34e-06	0.000555	CbGpPWpGaD
Fesoterodine—CHRM5—Signaling by GPCR—IL2—brain cancer	7.34e-06	0.000555	CbGpPWpGaD
Fesoterodine—CHRM3—Signaling by GPCR—PIK3CG—brain cancer	7.32e-06	0.000553	CbGpPWpGaD
Fesoterodine—CHRM4—Signaling Pathways—IRS2—brain cancer	7.28e-06	0.000551	CbGpPWpGaD
Fesoterodine—CHRM2—Signaling by GPCR—PIK3CG—brain cancer	7.25e-06	0.000548	CbGpPWpGaD
Fesoterodine—CHRM1—Signaling Pathways—NOTCH2—brain cancer	7.16e-06	0.000542	CbGpPWpGaD
Fesoterodine—ABCB1—Metabolism—ENO2—brain cancer	7.15e-06	0.000541	CbGpPWpGaD
Fesoterodine—CHRM3—Signaling Pathways—NOTCH2—brain cancer	7.14e-06	0.00054	CbGpPWpGaD
Fesoterodine—CHRM2—Signaling Pathways—NOTCH2—brain cancer	7.07e-06	0.000535	CbGpPWpGaD
Fesoterodine—CHRM5—Signaling Pathways—IRS2—brain cancer	6.97e-06	0.000527	CbGpPWpGaD
Fesoterodine—CHRM1—Signaling Pathways—VAV1—brain cancer	6.83e-06	0.000516	CbGpPWpGaD
Fesoterodine—CHRM3—Signaling Pathways—VAV1—brain cancer	6.81e-06	0.000515	CbGpPWpGaD
Fesoterodine—CHRM2—Signaling Pathways—VAV1—brain cancer	6.74e-06	0.00051	CbGpPWpGaD
Fesoterodine—CYP2D6—Metabolism—ENO2—brain cancer	6.74e-06	0.000509	CbGpPWpGaD
Fesoterodine—CYP3A4—Metabolism—BSG—brain cancer	6.48e-06	0.00049	CbGpPWpGaD
Fesoterodine—CHRM4—Signaling Pathways—PIK3CG—brain cancer	6.43e-06	0.000486	CbGpPWpGaD
Fesoterodine—CHRM4—Signaling Pathways—APC—brain cancer	6.43e-06	0.000486	CbGpPWpGaD
Fesoterodine—CHRM5—Signaling Pathways—PIK3CG—brain cancer	6.16e-06	0.000466	CbGpPWpGaD
Fesoterodine—CHRM5—Signaling Pathways—APC—brain cancer	6.16e-06	0.000466	CbGpPWpGaD
Fesoterodine—CHRM1—Signaling Pathways—HES1—brain cancer	5.87e-06	0.000444	CbGpPWpGaD
Fesoterodine—CHRM4—Signaling by GPCR—EGFR—brain cancer	5.86e-06	0.000443	CbGpPWpGaD
Fesoterodine—CHRM3—Signaling Pathways—HES1—brain cancer	5.85e-06	0.000443	CbGpPWpGaD
Fesoterodine—CHRM2—Signaling Pathways—HES1—brain cancer	5.8e-06	0.000438	CbGpPWpGaD
Fesoterodine—CHRM1—GPCR downstream signaling—IL2—brain cancer	5.69e-06	0.00043	CbGpPWpGaD
Fesoterodine—CHRM3—GPCR downstream signaling—IL2—brain cancer	5.67e-06	0.000429	CbGpPWpGaD
Fesoterodine—CHRM2—GPCR downstream signaling—IL2—brain cancer	5.61e-06	0.000425	CbGpPWpGaD
Fesoterodine—CHRM5—Signaling by GPCR—EGFR—brain cancer	5.61e-06	0.000424	CbGpPWpGaD
Fesoterodine—CHRM1—Signaling Pathways—PDGFRA—brain cancer	5.59e-06	0.000423	CbGpPWpGaD
Fesoterodine—CHRM3—Signaling Pathways—PDGFRA—brain cancer	5.57e-06	0.000421	CbGpPWpGaD
Fesoterodine—CYP3A4—Metabolism—IDH1—brain cancer	5.57e-06	0.000421	CbGpPWpGaD
Fesoterodine—CHRM2—Signaling Pathways—PDGFRA—brain cancer	5.52e-06	0.000417	CbGpPWpGaD
Fesoterodine—CHRM1—Signaling Pathways—SPP1—brain cancer	5.43e-06	0.00041	CbGpPWpGaD
Fesoterodine—CHRM3—Signaling Pathways—SPP1—brain cancer	5.41e-06	0.000409	CbGpPWpGaD
Fesoterodine—CHRM2—Signaling Pathways—SPP1—brain cancer	5.36e-06	0.000405	CbGpPWpGaD
Fesoterodine—CHRM3—Metabolism—PIK3CG—brain cancer	5.17e-06	0.000391	CbGpPWpGaD
Fesoterodine—CHRM1—Signaling by GPCR—IL2—brain cancer	5.17e-06	0.000391	CbGpPWpGaD
Fesoterodine—CHRM3—Signaling by GPCR—IL2—brain cancer	5.15e-06	0.000389	CbGpPWpGaD
Fesoterodine—CHRM2—Signaling by GPCR—IL2—brain cancer	5.1e-06	0.000386	CbGpPWpGaD
Fesoterodine—CHRM4—Signaling Pathways—RELA—brain cancer	5.02e-06	0.00038	CbGpPWpGaD
Fesoterodine—CHRM4—Signaling Pathways—ERBB2—brain cancer	4.99e-06	0.000378	CbGpPWpGaD
Fesoterodine—CHRM1—Signaling Pathways—IRS2—brain cancer	4.91e-06	0.000371	CbGpPWpGaD
Fesoterodine—CHRM3—Signaling Pathways—IRS2—brain cancer	4.89e-06	0.00037	CbGpPWpGaD
Fesoterodine—CHRM2—Signaling Pathways—IRS2—brain cancer	4.85e-06	0.000366	CbGpPWpGaD
Fesoterodine—CHRM5—Signaling Pathways—RELA—brain cancer	4.81e-06	0.000364	CbGpPWpGaD
Fesoterodine—CHRM5—Signaling Pathways—ERBB2—brain cancer	4.78e-06	0.000362	CbGpPWpGaD
Fesoterodine—CHRM4—Signaling Pathways—IL2—brain cancer	4.53e-06	0.000342	CbGpPWpGaD
Fesoterodine—CHRM4—Signaling Pathways—CCND1—brain cancer	4.41e-06	0.000334	CbGpPWpGaD
Fesoterodine—CYP3A4—Metabolism—ENO2—brain cancer	4.41e-06	0.000333	CbGpPWpGaD
Fesoterodine—CHRM4—Signaling Pathways—CTNNB1—brain cancer	4.37e-06	0.00033	CbGpPWpGaD
Fesoterodine—CHRM1—Signaling Pathways—APC—brain cancer	4.34e-06	0.000328	CbGpPWpGaD
Fesoterodine—CHRM1—Signaling Pathways—PIK3CG—brain cancer	4.34e-06	0.000328	CbGpPWpGaD
Fesoterodine—CHRM5—Signaling Pathways—IL2—brain cancer	4.33e-06	0.000328	CbGpPWpGaD
Fesoterodine—CHRM3—Signaling Pathways—PIK3CG—brain cancer	4.32e-06	0.000327	CbGpPWpGaD
Fesoterodine—CHRM3—Signaling Pathways—APC—brain cancer	4.32e-06	0.000327	CbGpPWpGaD
Fesoterodine—CHRM2—Signaling Pathways—APC—brain cancer	4.28e-06	0.000324	CbGpPWpGaD
Fesoterodine—CHRM2—Signaling Pathways—PIK3CG—brain cancer	4.28e-06	0.000324	CbGpPWpGaD
Fesoterodine—CHRM5—Signaling Pathways—CCND1—brain cancer	4.22e-06	0.000319	CbGpPWpGaD
Fesoterodine—CHRM5—Signaling Pathways—CTNNB1—brain cancer	4.18e-06	0.000316	CbGpPWpGaD
Fesoterodine—CHRM1—Signaling by GPCR—EGFR—brain cancer	3.95e-06	0.000299	CbGpPWpGaD
Fesoterodine—CHRM3—Signaling by GPCR—EGFR—brain cancer	3.94e-06	0.000298	CbGpPWpGaD
Fesoterodine—CHRM2—Signaling by GPCR—EGFR—brain cancer	3.9e-06	0.000295	CbGpPWpGaD
Fesoterodine—CHRM4—Signaling Pathways—VEGFA—brain cancer	3.85e-06	0.000291	CbGpPWpGaD
Fesoterodine—CHRM4—Signaling Pathways—STAT3—brain cancer	3.81e-06	0.000288	CbGpPWpGaD
Fesoterodine—CHRM5—Signaling Pathways—VEGFA—brain cancer	3.68e-06	0.000278	CbGpPWpGaD
Fesoterodine—CHRM5—Signaling Pathways—STAT3—brain cancer	3.65e-06	0.000276	CbGpPWpGaD
Fesoterodine—CHRM4—Signaling Pathways—MYC—brain cancer	3.54e-06	0.000268	CbGpPWpGaD
Fesoterodine—CHRM4—Signaling Pathways—EGFR—brain cancer	3.46e-06	0.000262	CbGpPWpGaD
Fesoterodine—CHRM5—Signaling Pathways—MYC—brain cancer	3.39e-06	0.000256	CbGpPWpGaD
Fesoterodine—CHRM1—Signaling Pathways—RELA—brain cancer	3.39e-06	0.000256	CbGpPWpGaD
Fesoterodine—CHRM3—Signaling Pathways—RELA—brain cancer	3.38e-06	0.000255	CbGpPWpGaD
Fesoterodine—CHRM1—Signaling Pathways—ERBB2—brain cancer	3.37e-06	0.000255	CbGpPWpGaD
Fesoterodine—CHRM3—Signaling Pathways—ERBB2—brain cancer	3.36e-06	0.000254	CbGpPWpGaD
Fesoterodine—CHRM2—Signaling Pathways—RELA—brain cancer	3.34e-06	0.000253	CbGpPWpGaD
Fesoterodine—CHRM2—Signaling Pathways—ERBB2—brain cancer	3.32e-06	0.000251	CbGpPWpGaD
Fesoterodine—CHRM5—Signaling Pathways—EGFR—brain cancer	3.31e-06	0.000251	CbGpPWpGaD
Fesoterodine—ABCB1—Metabolism—PIK3CG—brain cancer	3.28e-06	0.000248	CbGpPWpGaD
Fesoterodine—CYP2D6—Metabolism—PIK3CG—brain cancer	3.09e-06	0.000234	CbGpPWpGaD
Fesoterodine—CHRM1—Signaling Pathways—IL2—brain cancer	3.05e-06	0.000231	CbGpPWpGaD
Fesoterodine—CHRM3—Signaling Pathways—IL2—brain cancer	3.04e-06	0.00023	CbGpPWpGaD
Fesoterodine—CHRM2—Signaling Pathways—IL2—brain cancer	3.01e-06	0.000228	CbGpPWpGaD
Fesoterodine—CHRM1—Signaling Pathways—CCND1—brain cancer	2.97e-06	0.000225	CbGpPWpGaD
Fesoterodine—CHRM3—Signaling Pathways—CCND1—brain cancer	2.97e-06	0.000224	CbGpPWpGaD
Fesoterodine—CHRM1—Signaling Pathways—CTNNB1—brain cancer	2.95e-06	0.000223	CbGpPWpGaD
Fesoterodine—CHRM3—Signaling Pathways—CTNNB1—brain cancer	2.94e-06	0.000222	CbGpPWpGaD
Fesoterodine—CHRM2—Signaling Pathways—CCND1—brain cancer	2.94e-06	0.000222	CbGpPWpGaD
Fesoterodine—CHRM2—Signaling Pathways—CTNNB1—brain cancer	2.91e-06	0.00022	CbGpPWpGaD
Fesoterodine—CHRM4—Signaling Pathways—TP53—brain cancer	2.91e-06	0.00022	CbGpPWpGaD
Fesoterodine—CHRM5—Signaling Pathways—TP53—brain cancer	2.78e-06	0.00021	CbGpPWpGaD
Fesoterodine—CHRM1—Signaling Pathways—VEGFA—brain cancer	2.59e-06	0.000196	CbGpPWpGaD
Fesoterodine—CHRM3—Signaling Pathways—VEGFA—brain cancer	2.58e-06	0.000195	CbGpPWpGaD
Fesoterodine—CHRM1—Signaling Pathways—STAT3—brain cancer	2.57e-06	0.000194	CbGpPWpGaD
Fesoterodine—CHRM2—Signaling Pathways—VEGFA—brain cancer	2.56e-06	0.000194	CbGpPWpGaD
Fesoterodine—CHRM3—Signaling Pathways—STAT3—brain cancer	2.56e-06	0.000194	CbGpPWpGaD
Fesoterodine—CHRM2—Signaling Pathways—STAT3—brain cancer	2.53e-06	0.000192	CbGpPWpGaD
Fesoterodine—CHRM1—Signaling Pathways—MYC—brain cancer	2.39e-06	0.00018	CbGpPWpGaD
Fesoterodine—CHRM3—Signaling Pathways—MYC—brain cancer	2.38e-06	0.00018	CbGpPWpGaD
Fesoterodine—CHRM2—Signaling Pathways—MYC—brain cancer	2.36e-06	0.000178	CbGpPWpGaD
Fesoterodine—CHRM1—Signaling Pathways—EGFR—brain cancer	2.33e-06	0.000176	CbGpPWpGaD
Fesoterodine—CHRM3—Signaling Pathways—EGFR—brain cancer	2.33e-06	0.000176	CbGpPWpGaD
Fesoterodine—CHRM2—Signaling Pathways—EGFR—brain cancer	2.3e-06	0.000174	CbGpPWpGaD
Fesoterodine—CYP3A4—Metabolism—PIK3CG—brain cancer	2.02e-06	0.000153	CbGpPWpGaD
Fesoterodine—CHRM1—Signaling Pathways—TP53—brain cancer	1.96e-06	0.000148	CbGpPWpGaD
Fesoterodine—CHRM3—Signaling Pathways—TP53—brain cancer	1.95e-06	0.000148	CbGpPWpGaD
Fesoterodine—CHRM2—Signaling Pathways—TP53—brain cancer	1.93e-06	0.000146	CbGpPWpGaD
